The ligand HA was chosen, as HA was tumor-specific for receptor cluster of differentiation 44 (CD44), a membrane-anchored cell surface receptor usually detected in ovarian cancer cells, such as SKOV3 and SKOV3TR cells. The gene discussed is CD44; the disease is ovarian carcinoma.